Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.

Gressin R, Daguindau N, Tempescul A, Moreau A, Carras S, Tchernonog E, Schmitt A, Houot R, Dartigeas C, Pignon JM, Corm S, Banos A, Mounier C, Dupuis J, Macro M, Fleury J, Jardin F, Sarkozy C, Damaj G, Feugier P, Fornecker LM, Chabrot C, Dorvaux V, Bouadallah K, Amorin S, Garidi R, Voillat L, Joly B, Celigny PS, Morineau N, Moles MP, Zerazhi H, Fontan J, Arkam Y, Alexis M, Delwail V, Vilque JP, Ysebaert L, Le Gouill S, Callanan MB; Lymphoma Study Association.

Haematologica. 2019 Jan;104(1):138-146. doi: 10.3324/haematol.2018.191429. Epub 2018 Aug 31.

2.

Preliminary hazard analysis applied to outsourcing sterile chemotherapy preparations.

Geraudie B, Kabiche S, Rigal M, Malki M, Fontan JE, Jacolot A, Schlatter J.

J Oncol Pharm Pract. 2018 Jan 1:1078155218785239. doi: 10.1177/1078155218785239. [Epub ahead of print]

PMID:
29933726
3.

Development of a quantitative PCR detecting Cunninghamella bertholletiae to help in diagnosing this rare and aggressive mucormycosis.

Bellanger AP, Berceanu A, Rocchi S, Valot B, Fontan J, Chauchet A, Belin N, Scherer E, Deconinck E, Navellou JC, Millon L.

Bone Marrow Transplant. 2018 Sep;53(9):1180-1183. doi: 10.1038/s41409-018-0194-5. Epub 2018 Apr 30.

PMID:
29712993
4.

Oral pentobarbital suspension for children sedation during MR imaging.

Schlatter J, Kabiche S, Sellier N, Fontan JE.

Ann Pharm Fr. 2018 Jul;76(4):286-290. doi: 10.1016/j.pharma.2018.03.002. Epub 2018 Apr 11.

PMID:
29655484
5.

Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use.

Schlatter J, Nguyen D, Zamy M, Kabiche S, Fontan JE, Cisternino S.

Eur Spine J. 2017 Nov 18. doi: 10.1007/s00586-017-5387-x. [Epub ahead of print] Review.

PMID:
29151132
6.

Performing a preliminary hazard analysis applied to administration of injectable drugs to infants.

Hfaiedh N, Kabiche S, Delescluse C, Balde IB, Merlin S, Carret S, de Pontual L, Fontan JE, Schlatter J.

J Eval Clin Pract. 2017 Aug;23(4):875-881. doi: 10.1111/jep.12748. Epub 2017 May 4.

PMID:
28471070
7.

[Which useful Apps are installed on my smartphone as a clinical pharmacist?]

Mille F, Fontan JE, Bedouch P.

Ann Pharm Fr. 2017 Jul;75(4):309-317. doi: 10.1016/j.pharma.2017.02.002. Epub 2017 Apr 8. French.

PMID:
28395874
8.

Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.

Kabiche D, Balde IB, Majoul E, Kabiche S, Bourguignon E, Fontan JE, Cisternino S, Schlatter J.

Int J Pharm Compd. 2017 Mar-Apr;21(2):160-163.

PMID:
28346212
9.

Stability of suxamethonium in pharmaceutical solution for injection by validated stability-indicating chromatographic method.

Beck W, Kabiche S, Balde IB, Carret S, Fontan JE, Cisternino S, Schlatter J.

J Clin Anesth. 2016 Dec;35:551-559. doi: 10.1016/j.jclinane.2016.09.025. Epub 2016 Oct 23.

PMID:
27871592
10.

Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study.

Garderet L, Beohou E, Caillot D, Stoppa AM, Touzeau C, Chretien ML, Karlin L, Moreau P, Fontan J, Blaise D, Polge E, Gueye MS, Ikhlef S, Marjanovic Z, Labopin M, Mohty M.

Haematologica. 2016 Nov;101(11):1390-1397. Epub 2016 Sep 9.

11.

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.

Dejoie T, Corre J, Caillon H, Hulin C, Perrot A, Caillot D, Boyle E, Chretien ML, Fontan J, Belhadj K, Brechignac S, Decaux O, Voillat L, Rodon P, Fitoussi O, Araujo C, Benboubker L, Fontan C, Tiab M, Godmer P, Luycx O, Allangba O, Pignon JM, Fuzibet JG, Legros L, Stoppa AM, Dib M, Pegourie B, Orsini-Piocelle F, Karlin L, Arnulf B, Roussel M, Garderet L, Mohty M, Meuleman N, Doyen C, Lenain P, Macro M, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H.

Blood. 2016 Dec 22;128(25):2941-2948. doi: 10.1182/blood-2016-07-726778. Epub 2016 Oct 11.

12.

Stability-Indicating High-Performance Liquid Chromatography Assay for the Determination of Sulthiame in Pharmaceutical Dosage Forms.

Haidar A, Kabiche S, Majoul E, Balde IB, Fontan JE, Cisternino S, Schlatter J.

Anal Chem Insights. 2016 Sep 6;11:59-64. doi: 10.4137/ACI.S38656. eCollection 2016.

13.

Stability study of oral pediatric idebenone suspensions.

Schlatter J, Bourguignon E, Majoul E, Kabiche S, Balde IB, Cisternino S, Fontan JE.

Pharm Dev Technol. 2017 Mar;22(2):296-299. doi: 10.1080/10837450.2016.1231811. Epub 2016 Sep 21.

PMID:
27583702
14.

VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial.

Moreau P, Hulin C, Macro M, Caillot D, Chaleteix C, Roussel M, Garderet L, Royer B, Brechignac S, Tiab M, Puyade M, Escoffre M, Stoppa AM, Facon T, Pegourie B, Chaoui D, Jaccard A, Slama B, Marit G, Laribi K, Godmer P, Luycx O, Eisenmann JC, Allangba O, Dib M, Araujo C, Fontan J, Belhadj K, Wetterwald M, Dorvaux V, Fermand JP, Rodon P, Kolb B, Glaisner S, Malfuson JV, Lenain P, Biron L, Planche L, Caillon H, Avet-Loiseau H, Dejoie T, Attal M.

Blood. 2016 May 26;127(21):2569-74. doi: 10.1182/blood-2016-01-693580. Epub 2016 Mar 21.

15.

Stability of Pentobarbital in Water and Oral Pediatric Suspensions.

Schlatter J, Kabiche S, Balde IB, Majoul E, Cisternino S, Fontan JE.

Ann Pharmacother. 2016 Mar;50(3):245-6. doi: 10.1177/1060028015625655. Epub 2016 Jan 4. No abstract available.

PMID:
26728367
16.

Stability-Indicating HPLC Assay for Determination of Idebenone in Pharmaceutical Forms.

Kombath S, Balde IB, Carret S, Kabiche S, Cisternino S, Fontan JE, Schlatter J.

J Anal Methods Chem. 2015;2015:835986. doi: 10.1155/2015/835986. Epub 2015 Oct 29.

17.

Stability-Indicating Assay for the Determination of Pentobarbital Sodium in Liquid Formulations.

Ajemni M, Balde IB, Kabiche S, Carret S, Fontan JE, Cisternino S, Schlatter J.

Int J Anal Chem. 2015;2015:697937. doi: 10.1155/2015/697937. Epub 2015 Oct 12.

18.

Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?

Chretien ML, Corre J, Lauwers-Cances V, Magrangeas F, Cleynen A, Yon E, Hulin C, Leleu X, Orsini-Piocelle F, Blade JS, Sohn C, Karlin L, Delbrel X, Hebraud B, Roussel M, Marit G, Garderet L, Mohty M, Rodon P, Voillat L, Royer B, Jaccard A, Belhadj K, Fontan J, Caillot D, Stoppa AM, Attal M, Facon T, Moreau P, Minvielle S, Avet-Loiseau H.

Blood. 2015 Dec 17;126(25):2713-9. doi: 10.1182/blood-2015-06-650242. Epub 2015 Oct 29.

19.

Stability of Hydrocortisone Preservative-Free Oral Solutions.

Chappe J, Osman N, Cisternino S, Fontan JE, Schlatter J.

J Pediatr Pharmacol Ther. 2015 May-Jun;20(3):197-202. doi: 10.5863/1551-6776-20.3.197.

20.

Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial.

Rodon P, Hulin C, Pegourie B, Tiab M, Anglaret B, Benboubker L, Jardel H, Decaux O, Kolb B, Roussel M, Garderet L, Leleu X, Fitoussi O, Chaleteix C, Casassus P, Lenain P, Royer B, Banos A, Benramdane R, Cony-Makhoul P, Dib M, Fontan J, Stoppa AM, Traullé C, Vilque JP, Pétillon MO, Mathiot C, Dejoie T, Avet-Loiseau H, Moreau P.

Haematologica. 2015 Feb;100(2):e56-9. doi: 10.3324/haematol.2014.110890. Epub 2014 Nov 14. No abstract available.

21.

[Oral administration of medications to infants: Implementation of a preliminary risk analysis in a hospital service of pediatrics].

Pourrat M, Delescluse C, Merlin S, Sauvion S, Carret S, Fontan JE.

Ann Pharm Fr. 2014 Mar;72(2):112-21. doi: 10.1016/j.pharma.2013.11.002. Epub 2013 Dec 30. French.

PMID:
24630313
22.

Stability of betaxolol suspensions in oral syringes and glass bottles.

Auvity S, Chiadmi FM, Cisternino S, Fontan JE, Schlatter J.

Ann Pharmacother. 2013 Sep;47(9):1237-8. doi: 10.1177/1060028013503137. No abstract available.

PMID:
24259746
23.

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients.

Hebraud B, Leleu X, Lauwers-Cances V, Roussel M, Caillot D, Marit G, Karlin L, Hulin C, Gentil C, Guilhot F, Garderet L, Lamy T, Brechignac S, Pegourie B, Jaubert J, Dib M, Stoppa AM, Sebban C, Fohrer C, Fontan J, Fruchart C, Macro M, Orsini-Piocelle F, Lepeu G, Sohn C, Corre J, Facon T, Moreau P, Attal M, Avet-Loiseau H.

Leukemia. 2014 Mar;28(3):675-9. doi: 10.1038/leu.2013.225. Epub 2013 Jul 29.

24.

High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS study.

Gyan E, Damotte D, Courby S, Sénécal D, Quittet P, Schmidt-Tanguy A, Banos A, Le Gouill S, Lamy T, Fontan J, Maisonneuve H, Alexis M, Dreyfus F, Tournilhac O, Laribi K, Solal-Céligny P, Arakelyan N, Cartron G, Gressin R; GOELAMS Group.

Br J Haematol. 2013 Jul;162(2):240-9. doi: 10.1111/bjh.12379. Epub 2013 May 21.

PMID:
23692641
25.

A Rapid Stability-Indicating RP-HPLC Method for the Determination of Betaxolol Hydrochloride in Pharmaceutical Tablets.

Auvity S, Chiadmi F, Cisternino S, Fontan JE, Schlatter J.

Anal Chem Insights. 2013;8:1-7. doi: 10.4137/ACI.S11256. Epub 2013 Mar 11.

26.

Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Garderet L, Iacobelli S, Moreau P, Dib M, Lafon I, Niederwieser D, Masszi T, Fontan J, Michallet M, Gratwohl A, Milone G, Doyen C, Pegourie B, Hajek R, Casassus P, Kolb B, Chaleteix C, Hertenstein B, Onida F, Ludwig H, Ketterer N, Koenecke C, van Os M, Mohty M, Cakana A, Gorin NC, de Witte T, Harousseau JL, Morris C, Gahrton G.

J Clin Oncol. 2012 Jul 10;30(20):2475-82. doi: 10.1200/JCO.2011.37.4918. Epub 2012 May 14. Erratum in: J Clin Oncol. 2012 Sep 20;30(27):3429. J Clin Oncol. 2014 Apr 20;32(12):1285.

PMID:
22585692
27.

Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.

Moreau P, Avet-Loiseau H, Facon T, Attal M, Tiab M, Hulin C, Doyen C, Garderet L, Randriamalala E, Araujo C, Lepeu G, Marit G, Caillot D, Escoffre M, Lioure B, Benboubker L, Pégourié B, Kolb B, Stoppa AM, Fuzibet JG, Decaux O, Dib M, Berthou C, Chaleteix C, Sebban C, Traullé C, Fontan J, Wetterwald M, Lenain P, Mathiot C, Harousseau JL.

Blood. 2011 Nov 24;118(22):5752-8; quiz 5982. doi: 10.1182/blood-2011-05-355081. Epub 2011 Aug 17.

28.

Successful mobilization and engraftment of PBSCs derived from donor cord blood cells after a previous allogeneic RIC single unrelated cord blood transplantation.

Larosa F, Deconinck E, Helias P, Fontan J, Heczko M, Brion A, Ledu K, Delaby P, Vuiller J, Ferrand C, Saas P, Pouthier F, Dormoy A, Chabod J, Malugani C, Rohrlich PS, Legrand F.

Blood. 2011 Jul 14;118(2):476-8. doi: 10.1182/blood-2011-03-343640. No abstract available.

29.

Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.

Brion A, Legrand F, Larosa F, Schillinger F, Garnache-Ottou F, Helias P, Fontan J, Heczko M, Delaby P, Daguindau E, Vuillier J, Chauchet A, Deconinck E.

Invest New Drugs. 2012 Aug;30(4):1697-702. doi: 10.1007/s10637-011-9632-6. Epub 2011 Jan 13.

PMID:
21229289
30.

Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial.

Moreau P, Attal M, Pégourié B, Planche L, Hulin C, Facon T, Stoppa AM, Fuzibet JG, Grosbois B, Doyen C, Ketterer N, Sebban C, Kolb B, Chaleteix C, Dib M, Voillat L, Fontan J, Garderet L, Jaubert J, Mathiot C, Esseltine D, Avet-Loiseau H, Harousseau JL; IFM 2005-01 study investigators.

Blood. 2011 Mar 17;117(11):3041-4. doi: 10.1182/blood-2010-08-300863. Epub 2010 Nov 23. Erratum in: Blood. 2012 Nov 15;120(20):4274.

31.

Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.

Hulin C, Facon T, Rodon P, Pegourie B, Benboubker L, Doyen C, Dib M, Guillerm G, Salles B, Eschard JP, Lenain P, Casassus P, Azaïs I, Decaux O, Garderet L, Mathiot C, Fontan J, Lafon I, Virion JM, Moreau P.

J Clin Oncol. 2009 Aug 1;27(22):3664-70. doi: 10.1200/JCO.2008.21.0948. Epub 2009 May 18.

PMID:
19451428
32.

Analysis of overridden alerts in a drug-drug interaction detection system.

Mille F, Schwartz C, Brion F, Fontan JE, Bourdon O, Degoulet P, Jaulent MC.

Int J Qual Health Care. 2008 Dec;20(6):400-5. doi: 10.1093/intqhc/mzn038. Epub 2008 Sep 10.

PMID:
18784269
33.

A case of invasive rhinosinusitis by Fusarium verticillioides (Saccardo) Nirenberg in an apparently immunocompetent patient.

Macêdo DP, Neves RP, Fontan J, Souza-Motta CM, Lima D.

Med Mycol. 2008 Aug;46(5):499-503. doi: 10.1080/13693780701861462. Epub 2008 Mar 5.

PMID:
18608897
34.

Treatment of congenital afibrinogenemia in a premature neonate.

Toledano A, Lachassinne E, Roumegoux C, Laurian Y, Benabadji Z, Chiadmi F, Cisternino S, Schlatter J, Fontan JE.

Ann Pharmacother. 2008 Jul;42(7):1145-6. doi: 10.1345/aph.1L132. Epub 2008 Jun 17. No abstract available.

PMID:
18559953
35.

Comparison of field methods to estimate fat mass in children.

Paineau D, Chiheb S, Banu I, Valensi P, Fontan JE, Gaudelus J, Chapalain V, Chumlea C, Bornet F, Boulier A.

Ann Hum Biol. 2008 Mar-Apr;35(2):185-97. doi: 10.1080/03014460801914874.

PMID:
18428012
36.
37.

Stability of oxaliplatin in infusion bags containing 5% dextrose injection.

André P, Cisternino S, Roy AL, Chiadmi F, Schlatter J, Agranat P, Fain O, Fontan JE.

Am J Health Syst Pharm. 2007 Sep 15;64(18):1950-4.

PMID:
17823107
38.

[Misoprostol for treating postpartum hemorrhages].

Godard C, Berhoune M, Bertrand E, Schlatter J, Chiadmi F, Toledano A, Cisternino S, Fontan JE.

Presse Med. 2008 Mar;37(3 Pt 2):477-84. Epub 2007 Jul 23. Review. French.

PMID:
17643941
39.

Plasma proteins in health and disease: a scientific symposium to celebrate the career and accomplishments of Harvey R. Colten, M.D.

Fontan JP, Dowton SB, Perlmutter D, Gitlin J, Cole FS.

Pediatr Res. 2006 Aug;60(2):231-2. No abstract available.

PMID:
16864710
40.

Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections.

Sahraoui L, Chiadmi F, Schlatter J, Toledano A, Cisternino S, Fontan JE.

Am J Health Syst Pharm. 2006 Aug 1;63(15):1423-6. No abstract available.

PMID:
16849707
41.

[Pediatric medication errors and their prevention].

Brion F, Prot-Labarthe S, Bourdon O, Masseron S, Awaïda L, Fontan JE.

Bull Acad Natl Med. 2005 Nov;189(8):1711-9; discussion 1719. French.

PMID:
16737096
42.

Granulomatous hepatitis and hemophagocytic syndrome after bacillus Calmette-Guerin bladder instillation.

Thevenot T, Di Martino V, Lagrange A, Petrella T, Faucher JF, Fontan J, Terebus M, Miguet JP, Bresson-Hadni S.

Gastroenterol Clin Biol. 2006 Mar;30(3):480-2.

43.

Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy.

Mok E, Eléouet-Da Violante C, Daubrosse C, Gottrand F, Rigal O, Fontan JE, Cuisset JM, Guilhot J, Hankard R.

Am J Clin Nutr. 2006 Apr;83(4):823-8.

PMID:
16600934
44.

Estimating body composition in children with Duchenne muscular dystrophy: comparison of bioelectrical impedance analysis and skinfold-thickness measurement.

Mok E, Béghin L, Gachon P, Daubrosse C, Fontan JE, Cuisset JM, Gottrand F, Hankard R.

Am J Clin Nutr. 2006 Jan;83(1):65-9.

PMID:
16400051
45.

Stability of levamisole oral solutions prepared from tablets and powder.

Chiadmi F, Lyer A, Cisternino S, Toledano A, Schlatter J, Ratiney R, Fontan JE.

J Pharm Pharm Sci. 2005 Aug 12;8(2):322-5.

46.

Drug administration errors and their determinants in pediatric in-patients.

Prot S, Fontan JE, Alberti C, Bourdon O, Farnoux C, Macher MA, Foureau A, Faye A, Beaufils F, Gottot S, Brion F.

Int J Qual Health Care. 2005 Oct;17(5):381-9. Epub 2005 Aug 22.

PMID:
16115809
47.

[Drug interactions in an elderly population. Prospective assessment of their frequency and seriousness among 56 patients].

Barré E, Bisseux L, Chiadmi F, Toledano A, Cisternino S, Schlatter J, Champault G, Ratiney R, Fontan JE.

Presse Med. 2005 Jul 2;34(12):837-41. French.

48.

Stability of bortezomib 1-mg/mL solution in plastic syringe and glass vial.

André P, Cisternino S, Chiadmi F, Toledano A, Schlatter J, Fain O, Fontan JE.

Ann Pharmacother. 2005 Sep;39(9):1462-6. Epub 2005 Jun 28.

PMID:
15985470
49.

Stability of misoprostol in suppositories.

Hafirassou H, Chiadmi F, Schlatter J, Ratiney R, Fontan JE.

Am J Health Syst Pharm. 2005 Jun 1;62(11):1192-4. No abstract available.

PMID:
15914880
50.

Stability of doxorubicin combined with Radioselectan, a contrast agent, for chemoembolization.

Chiadmi F, Daroso J, Schlatter J, Cisternino S, Ratiney R, Fontan JE.

J Clin Pharm Ther. 2005 Jun;30(3):255-8.

PMID:
15896243

Supplemental Content

Loading ...
Support Center